Viewing Study NCT05825066


Ignite Creation Date: 2025-12-24 @ 4:36 PM
Ignite Modification Date: 2025-12-27 @ 12:12 AM
Study NCT ID: NCT05825066
Status: RECRUITING
Last Update Posted: 2025-05-30
First Post: 2023-04-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
Sponsor: Wake Forest University Health Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module